16/04/2019
ATG is a synthetic biology and biotechnology company. We offer straightforward gene synthesis, gene optimization and expression systems but are specifically experts for synthetic bioinformatics that enable complex combinatorial gene designs, multi-gene expression strategies and projects involving gene cluster design.
We offer bioinformatics and wet-lab expertise, products and services. Our mainstays are multi-gene and multi-peptide expression products and services along with bioinformatics analysis and work-up for academic and industrial R&D in the fields of drug discovery, industrial and medical biotechnology, molecular diagnostics, and bioengineering.
ATG is also looking for strategic partnerships and outsourcing projects that aim at developing and marketing high-potential applications, e.g. DNA- and protein based vaccines.